Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
Hepatology International · 2024-04 · 18 (2) · 700-701
DOI: 10.1007/s12072-024-10664-8 ↗Kurz gefasst
Leserbrief in der Zeitschrift Hepatology International, online erschienen am 29.02.2024. Verfasst von Jin Wook Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gastroenterology and Hepatology, Soonchunhyang University School of Medicine, Bucheon, South Korea. Hauptthemen laut MEDLINE: Alanine, Antiviral Agents, Dyslipidemias, Hepatitis B, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Gastroenterology and Hepatology, Soonchunhyang University School of Medicine, Bucheon, South Korea.
- Department of Internal Medicine, Gastroenterology and Hepatology, Soonchunhyang University School of Medicine, Bucheon, South Korea. puby17@naver.com.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, 170 Jomaruro Wonmigu, Bucheonsi, Gyeonggido, 14584, Republic of Korea. puby17@naver.com.
Zitieren
APA
Park, J. W., Yoo, J. J., Kim, S. G., & Kim, Y. S. (2024). Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis. Hepatology International, 18(2), 700-701. https://doi.org/10.1007/s12072-024-10664-8
Vancouver
Park JW, Yoo JJ, Kim SG, Kim YS. Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis. Hepatology International. 2024;18(2):700-701. doi:10.1007/s12072-024-10664-8
BibTeX
@article{Park2024,
author = {Park, Jin Wook and Yoo, Jeong-Ju and Kim, Sang Gyune and Kim, Young Seok},
title = {Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis},
journal = {Hepatology International},
year = {2024},
volume = {18},
number = {2},
pages = {700--701},
doi = {10.1007/s12072-024-10664-8}
}
EUVIMED